Literature DB >> 20852949

Further research on Xyrem®/sodium oxybate treatment of patients with obstructive sleep apnea is needed.

Deborah L Zvosec, Stephen W Smith, Mark W Mahowald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20852949     DOI： 10.1007/s11325-010-0413-9

Source DB:  PubMed          Journal:  Sleep Breath        ISSN： 1520-9512            Impact factor:   2.816


× No keyword cloud information.
  8 in total

1.  Rigorous study of Xyrem®/sodium oxybate use among patients with obstructive sleep apnea and other conditions of compromised respiratory function is critically needed.

Authors:  Deborah L Zvosec; Stephen W Smith; Mark W Mahowald
Journal:  Sleep Med       Date:  2011-01       Impact factor: 3.492

2.  A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.

Authors:  Mortimer Mamelak; Jed Black; Jacques Montplaisir; Ruzica Ristanovic
Journal:  Sleep       Date:  2004-11-01       Impact factor: 5.849

3.  Use of sodium oxybate (Xyrem in patients with dual diagnosis of narcolepsy and sleep apnea.

Authors:  Ruzica Kovacević-Ristanović; Tomasz J Kuźniar
Journal:  Sleep Med       Date:  2009-12-04       Impact factor: 3.492

4.  A multi-drug intoxication fatality involving Xyrem (GHB).

Authors:  Brianne E Akins; Estuardo Miranda; J Matthew Lacy; Barry K Logan
Journal:  J Forensic Sci       Date:  2009-01-29       Impact factor: 1.832

5.  Three deaths associated with use of Xyrem.

Authors:  Deborah L Zvosec; Stephen W Smith; Brad J Hall
Journal:  Sleep Med       Date:  2009-03-09       Impact factor: 3.492

6.  A safety trial of sodium oxybate in patients with obstructive sleep apnea: Acute effects on sleep-disordered breathing.

Authors:  Charles F P George; Neil Feldman; Neil Inhaber; Teresa L Steininger; Susanna M Grzeschik; Chinglin Lai; Yanping Zheng
Journal:  Sleep Med       Date:  2009-11-07       Impact factor: 3.492

Review 7.  Clinical perspective: monitoring sodium oxybate-treated narcolepsy patients for the development of sleep-disordered breathing.

Authors:  Neil T Feldman
Journal:  Sleep Breath       Date:  2009-07-23       Impact factor: 2.816

8.  A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome.

Authors:  Charles F P George; Neil Feldman; Yanping Zheng; Teresa L Steininger; Susanna M Grzeschik; Chinglin Lai; Neil Inhaber
Journal:  Sleep Breath       Date:  2010-01-18       Impact factor: 2.816
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.